BMB-202 is a selective serotonin 5-HT2A receptor agonist and psychedelic drug of the N-benzylphenethylamine family which is under development for the treatment of depressive disorders and post-traumatic stress disorder (PTSD). It is taken orally.
BMB-202 is a selective serotonin 5-HT2A receptor agonist and psychedelic drug of the N-benzylphenethylamine family which is under development for the treatment of depressive disorders and post-traumatic stress disorder (PTSD). It is taken orally.
Source: Wikipedia "BMB-202" · CC BY-SA 4.0
Share this article: X · Bluesky